Increase in the septal vasopressin content by prolyl endopeptidase inhibitors in rats

Naoyoshi Miura, Shigenobu Shibata, Shigenori Watanabe

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Prolyl endopeptidase (PEP; EC 3.4.21.26) cleaves the Pro-Arg bond of arginine-vasopressin (AVP). This study investigated the effects of PEP inhibitors, 1-[1-(benzyloxycarbonyl)-l-prolyl]prolinal (Z-Pro-prolinal) and 1-[3-(2-indanylacetyl)-L-thioprolyl]pyrrolidine (Z-321), on the AVP content in the septum of rats. Oral administration of Z-Pro-prolinal (100 mg/kg) and Z-321 (100 mg/kg) significantly increased the septal AVP content. At 10 mg/kg, Z-321 slightly increased the content. In contrast, the d-thioprolyl form of Z-321 (100 mg/kg), which lacks an inhibitory effect on the enzyme, failed to affect the AVP content. These results indicate that PEP inhibitors increase the content of AVP through inhibition of the enzyme activity in vivo. Therefore, it is suggested that PEP may contribute to the degradation of endogenous AVP in the brain.

Original languageEnglish
Pages (from-to)128-130
Number of pages3
JournalNeuroscience Letters
Volume196
Issue number1-2
DOIs
Publication statusPublished - 1995 Aug 18
Externally publishedYes

Fingerprint

prolyl oligopeptidase
Arginine Vasopressin
Protease Inhibitors
Vasopressins
prolylarginine
Enzymes
Oral Administration
1-(3-(2-indanylacetyl)-L-thioprolyl)pyrrolidine
Peptamen

Keywords

  • Arginine-vasopressin
  • Inhibitors
  • Metabolism
  • Prolyl endopeptidase
  • Septum

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Increase in the septal vasopressin content by prolyl endopeptidase inhibitors in rats. / Miura, Naoyoshi; Shibata, Shigenobu; Watanabe, Shigenori.

In: Neuroscience Letters, Vol. 196, No. 1-2, 18.08.1995, p. 128-130.

Research output: Contribution to journalArticle

Miura, Naoyoshi ; Shibata, Shigenobu ; Watanabe, Shigenori. / Increase in the septal vasopressin content by prolyl endopeptidase inhibitors in rats. In: Neuroscience Letters. 1995 ; Vol. 196, No. 1-2. pp. 128-130.
@article{8a257af4c22b4183ab1f62437b493f11,
title = "Increase in the septal vasopressin content by prolyl endopeptidase inhibitors in rats",
abstract = "Prolyl endopeptidase (PEP; EC 3.4.21.26) cleaves the Pro-Arg bond of arginine-vasopressin (AVP). This study investigated the effects of PEP inhibitors, 1-[1-(benzyloxycarbonyl)-l-prolyl]prolinal (Z-Pro-prolinal) and 1-[3-(2-indanylacetyl)-L-thioprolyl]pyrrolidine (Z-321), on the AVP content in the septum of rats. Oral administration of Z-Pro-prolinal (100 mg/kg) and Z-321 (100 mg/kg) significantly increased the septal AVP content. At 10 mg/kg, Z-321 slightly increased the content. In contrast, the d-thioprolyl form of Z-321 (100 mg/kg), which lacks an inhibitory effect on the enzyme, failed to affect the AVP content. These results indicate that PEP inhibitors increase the content of AVP through inhibition of the enzyme activity in vivo. Therefore, it is suggested that PEP may contribute to the degradation of endogenous AVP in the brain.",
keywords = "Arginine-vasopressin, Inhibitors, Metabolism, Prolyl endopeptidase, Septum",
author = "Naoyoshi Miura and Shigenobu Shibata and Shigenori Watanabe",
year = "1995",
month = "8",
day = "18",
doi = "10.1016/0304-3940(95)11821-D",
language = "English",
volume = "196",
pages = "128--130",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "1-2",

}

TY - JOUR

T1 - Increase in the septal vasopressin content by prolyl endopeptidase inhibitors in rats

AU - Miura, Naoyoshi

AU - Shibata, Shigenobu

AU - Watanabe, Shigenori

PY - 1995/8/18

Y1 - 1995/8/18

N2 - Prolyl endopeptidase (PEP; EC 3.4.21.26) cleaves the Pro-Arg bond of arginine-vasopressin (AVP). This study investigated the effects of PEP inhibitors, 1-[1-(benzyloxycarbonyl)-l-prolyl]prolinal (Z-Pro-prolinal) and 1-[3-(2-indanylacetyl)-L-thioprolyl]pyrrolidine (Z-321), on the AVP content in the septum of rats. Oral administration of Z-Pro-prolinal (100 mg/kg) and Z-321 (100 mg/kg) significantly increased the septal AVP content. At 10 mg/kg, Z-321 slightly increased the content. In contrast, the d-thioprolyl form of Z-321 (100 mg/kg), which lacks an inhibitory effect on the enzyme, failed to affect the AVP content. These results indicate that PEP inhibitors increase the content of AVP through inhibition of the enzyme activity in vivo. Therefore, it is suggested that PEP may contribute to the degradation of endogenous AVP in the brain.

AB - Prolyl endopeptidase (PEP; EC 3.4.21.26) cleaves the Pro-Arg bond of arginine-vasopressin (AVP). This study investigated the effects of PEP inhibitors, 1-[1-(benzyloxycarbonyl)-l-prolyl]prolinal (Z-Pro-prolinal) and 1-[3-(2-indanylacetyl)-L-thioprolyl]pyrrolidine (Z-321), on the AVP content in the septum of rats. Oral administration of Z-Pro-prolinal (100 mg/kg) and Z-321 (100 mg/kg) significantly increased the septal AVP content. At 10 mg/kg, Z-321 slightly increased the content. In contrast, the d-thioprolyl form of Z-321 (100 mg/kg), which lacks an inhibitory effect on the enzyme, failed to affect the AVP content. These results indicate that PEP inhibitors increase the content of AVP through inhibition of the enzyme activity in vivo. Therefore, it is suggested that PEP may contribute to the degradation of endogenous AVP in the brain.

KW - Arginine-vasopressin

KW - Inhibitors

KW - Metabolism

KW - Prolyl endopeptidase

KW - Septum

UR - http://www.scopus.com/inward/record.url?scp=0029125636&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029125636&partnerID=8YFLogxK

U2 - 10.1016/0304-3940(95)11821-D

DO - 10.1016/0304-3940(95)11821-D

M3 - Article

C2 - 7501240

AN - SCOPUS:0029125636

VL - 196

SP - 128

EP - 130

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 1-2

ER -